The Food and Drug Administration (FDA) granted emergency use authorization for an updated version of the Novavax COVID-19 vaccine amid the summer surge of infections. The new version of the ...
"Today's authorization provides an additional COVID-19 vaccine option," said Peter Marks, director of the FDA's Center for Biologics ... 2024-25 COVID-19 vaccines. Novavax's traditional protein ...
The U.S. Food and Drug Administration on Friday authorized the updated version of the protein-based Novavax Covid-19 vaccine for use in people 12 and older. Advertisement One week ago, the FDA ...